Malignant mammary tumors: Biologic behavior, prognostic factors, and therapeutic approach in cats - Veterinary Medicine
  • SEARCH:
Medicine Center
DVM Veterinary Medicine Featuring Information from:

ADVERTISEMENT

Malignant mammary tumors: Biologic behavior, prognostic factors, and therapeutic approach in cats
Most mammary tumors in cats are malignant, and metastasis is common. The prognosis depends on how far the cancer has spread and the tumor's biologic behavior, among other things. Find out how to improve the outcome in these critically ill cats.


VETERINARY MEDICINE


34. de las Mulas JM, van Niel M, Millan Y, et al. Immunohistochemical analysis of estrogen receptors in feline mammary gland benign and malignant lesions: comparison with biochemical assay. Domest Anim Endocrinol 2000;18:111-125.

35. de las Mulas JM, van Niel M, Millan Y, et al. Progesterone receptors in normal, dysplastic and tumourous feline mammary glands. Comparison with oestrogen receptors status. Res Vet Sci 2002;72:153-161.

36. Dutra AP, Granja NV, Schmitt FC, et al. c-erbB-2 expression and nuclear pleomorphism in canine mammary tumors. Braz J Med Biol Res 2004;37:1673-1681.

37. Ahern TE, Bird RC, Bird AE, et al. Expression of the oncogene c-erbB-2 in canine mammary cancers and tumor-derived cell lines. Am J Vet Res 1996;57:693-696.

38. De Maria R, Olivero M, Iussich S, et al. Spontaneous feline mammary carcinoma is a model of HER2 overexpressing poor prognosis human breast cancer. Cancer Res 2005;65:907-912.

39. MacEwen EG, Hayes AA, Harvey HJ, et al. Prognostic factors for feline mammary tumors. J Am Vet Med Assoc 1984;185:201-204.

40. Castagnaro M, De Maria R, Bozzetta E, et al. Ki-67 index as indicator of the post-surgical prognosis in feline mammary carcinomas. Res Vet Sci 1998;65:223-226.

41. Castagnaro M, Casalone C, Bozzetta E, et al. Tumor grading and the one-year post-surgical prognosis in feline mammary carcinomas. J Comp Pathol 1998;119:263-275.

42. Mauldin GE, Mooney SC, Patnaik AK. Adjuvant doxorubicin for feline mammary adenocarcinoma, in Proceedings. 14th Annu Vet Cancer Soc Conf 1994.

43. Novosad CA, Bergman PJ, O'Brien MG, et al. Retrospective evaluation of adjunctive doxorubicin for the treatment of feline mammary gland adenocarcinoma: 67 cases. J Am Anim Hosp Assoc 2006;42:110-120.

44. Jeglum KA, deGuzman E, Young KM. Chemotherapy of advanced mammary adenocarcinoma in 14 cats. J Am Vet Med Assoc 1985;187:157-160.

45. Mauldin GN, Matus RE, Patnaik AK, et al. Efficacy and toxicity of doxorubicin and cyclophosphamide used in the treatment of selected malignant tumors in 23 cats. J Vet Intern Med 1988;2:60-65.

46. Dhaliwal RS, Kitchell BE, Hintermeister J. Efficacy of carboplatin in feline mammary carcinoma (abst), in Proceedings. 20th Annu Am Coll Vet Intern Med 2002.

47. Fox LE, MacEwen EG, Kurzman ID, et al. Liposome-encapsulated muramyl tripeptide phosphatidylethanolamine for the treatment of feline mammary adenocarcinoma—a multicenter randomized double-blind study. Cancer Biother 1995;10:125-130.

48. MacEwen EG, Hayes AA, Mooney S, et al. Evaluation of effect of levamisole on feline mammary cancer. J Biol Response Mod 1984;3:541-546.

49. Viste JR, Myers SL, Singh B, et al. Feline mammary adenocarcinoma: tumor size as a prognostic indicator. Can Vet J 2002;43:33-37.

50. Ozawa S, Minami T, Utsunomiya H, et al. Study on histopathological prognostication of mammary gland tumor in cat (97 cases), in Proceedings. 14th Annu Vet Cancer Soc Conf 2002.


ADVERTISEMENT


Click here